I-cell disease

Lysosomal Storage Disorders

Volumn , Issue , 2007, Pages 529-537

  Brooks, Doug ^a,b   Turner, Chris ^a   Muller, Viv ^a   Hopwood, John J ^a,b   Meikle, Peter ^a,b  

^a Lysosomal Diseases Research Unit   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84878107467     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-70909-3_33     Document Type: Chapter

References (34)

1. Bao, M., Booth, J. L., Elmendorf, B. J., and Canfield, W. M., 1996, Bovine UDP-N-acetylglucosamine: lysosomal-enzyme N-acetylglucosamine-1-phosphotransferase: I. Purification and subunit structure. J. Biol. Chem. 271:31437.
2. Boman, A. L., Zhang, C., Zhu, X., and Kahn, R. A., 2000, A family of ADP-ribosylation factor effectors that can alter membrane transport through the trans-Golgi, Mol. Biol. Cell. 11:1241.
3. Bosshard, N. U., Hubler, M., Arnold, S., Briner, J., Spycher, M. A., Sommerlade, H. J., von Figura, K., and Gitzelmann, R., 1996, Spontaneous mucolipidosis in a cat: An animal model of human I-cell disease, Vet. Pathol. 33:1.
4. Brown, W. J., and Farquhar, M. G., 1984, Accumulation of coated vesicles bearing mannose 6-phosphate receptors for lysosomal enzymes in the Golgi region of I-cell fibroblasts, Proc. Natl. Acad. Sci. U S A. 81:5135.
5. D'Azzo, A., Halley, D. J., Hoogeveen, A., and Galjaard, H., 1980, Correction of I-cell defect by hybridization with lysosomal enzyme deficient human fibroblasts, Am. J. Hum. Genet. 32:519.
6. Dell'Angelica, E. C., Mullins, C., Caplans, S., and Bonifacino, J. S., 2000, Lysosome-related organelles, FASEB J. 14:1265.
7. Dittmer, F., Hafner, A., Ulbrich, E. J., Moritz, J. D., Schmidt, P., Schmahl, W., Pohlmann, R., and von Figura, K., 1998, I-cell disease-like phenotype in mice deficient in mannose 6-phosphate receptors, Transgenic. Res. 7:473.
8. Grewal, S., Shapiro, E., Braunlin, E., Charnas, L., Krivit, W., Orchard, P., and Peters, C., 2003, Continued neurocognitive development and prevention of cardiopulmonary complications after successful BMT for I-cell disease: A long-term follow-up report, Bone Marrow Transplant. 32:957.
9. Hickman, S., and Neufeld, E. F., 1992, A hypothesis for I-cell disease: Defective hydrolases that do not enter lysosomes, Biochem. Biophys. Res. Commun. 49:992.
10. Hirst, J., Lui, W. W., Bright, N. A., Totty, N., Seaman, M. N., and Robinson, M. S., 2000, A family of proteins with gamma-adaptin and VHS domains that facilitate trafficking between the trans-Golgi network and the vacuole/lysosome, J. Cell Biol. 149:67.
11. Honey, N. K., Mueller, O. T., Little, L. E., Miller, A. L., and Shows, T. B., 1982, Mucoli-pidosis III is genetically heterogeneous, Proc. Natl. Acad. Sci. U S A. 79:7420.
12. Hubler, M., Haskins, M. E., Arnold, S., Kaser-Hotz, B., Bosshard, N. U., Briner, J., Spycher, M. A., Gitzelmann, R., Sommerlade, H. J., and von Figura, K., 1996, Mucolipidosis type II in a domestic shorthair cat, J. Small Anim. Pract. 37:435.
13. Hwu, W. L., Chuang, S. C., Wang, W. C., and Wang, T. R., 1994, Diagnosis of I-cell disease, Zhonghua. Min. Guo. Xiao. Er. Ke. Yi. Xue. Hui. Za. Zhi. 35:508.
14. Imaizumi, M., Gushi, K., Kurobane, I., Inoue, S., Suzuki, J., Koizumi, Y., Suzuki, H., Sato, A., Gotoh, Y., Haginoya, K., et al., 1994, Long-term effects of bone marrow transplantation for inborn errors of metabolism: A study of four patients with lyso-somal storage diseases, Acta. Paediatr. Jpn. 36:30.
15. Kornfeld, S., and Sly, W. S., 1999, I-cell disease and pseudo-hurler polydystrophy: disorders of lysosomal phosphorylation and localisation, In Metabolic Basis of Inherited Diseases. Chapter 79 (McGraw-Hill, New York) pp. 2495-2508.
16. Kornfeld, R., Bao, M., Brewer, K., Noll, C., and Canfield, W., 1999, Molecular cloning and functional expression of two splice forms of human N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase, J. Biol. Chem. 274:32778.
17. Kurobane, I., Inoue, S., Gotoh, Y., Kato, S., Tamura, M., Narisawa, K., and Tada, K., 1986, Biochemical improvement after treatment by bone marrow transplantation in I-cell disease, Tohoku J. Exp. Med. 150:63.
18. Leroy, J. G., and De Mars, R. I., 1967, Mutant enzymatic and cytological phenotypes in cultured human fibroblasts, Science. 157:804.
19. Little, L. E., Mueller, O. T., Honey, N. K., Shows, T. B., and Miller, A. L., 1986, Heterogeneity of N-acetyylglucosamine 1-phosphotransferase within mucolipidosis III, J. Biol. Chem. 261:733.
20. Maroteaux, P., and Lamy, M., 1966, La pseudo-polydystrophie de Hurler, Presse Med. 74:2889.
21. Mazrier, H., Van Hoeven, M., Wang, P., Knox, V. W., Aguirre, G. D., Holt, E., Wiemelt, S. P., Sleeper, M. M., Hubler, M., Haskins, M. E., and Giger, U., 2003, Inheritance, biochemical abnormalities, and clinical features of feline mucolipidosis II: The first animal model of human I-cell disease, J. Hered. 94:363.
22. Meikle, P. J., Brooks, D. A., Ravenscroft, E. M., Yan, M., Williams, R. E., Jaunzems, A. E., Chataway, T. K., Karageorgos, L. E., Davey, R. C., Boulter, C. D., Carlsson, S. R., and Hopwood, JJ., 1997, Diagnosis of lysosomal storage disorders: Evaluation of lysosome-associated membrane protein LAMP-1 as a diagnostic marker, Clin. Chem. 43:1325.
23. Raas-Rothschild, A., Bargal, R., Goldman, O., Ben-Asher, E., Groener, J. E., Toutain, A., Stemmer, E., Ben-Neriah, Z., Flusser, H., Beemer, F. A., Penttinen, M., Olender, T., Rein, A. J., Bach, G., and Zeigler, M., 2004, Genomic organisation of the UDP-N-acetylglucosamine-1-phosphotransferase gamma subunit (GNPTAG) and its mutations in mucolipidosis III, J. Med. Genet. 41:e52.
24. Raas-Rothschild, A., Cormier-Daire, V., Bao, M., Genin, E., Salomon, R., Brewer, K., Zeigler, M., Mandel, H., Toth, S., Roe, B., Munnich, A., and Canfield, W. M., 2000, Molecular basis of variant pseudo-Hurler polydystrophy (mucolipidosis IIIC), J. Clin. Invest. 105:673.
25. Robinson, C., Baker, N., Noble, J., King, A., David, G., Sillence, D., Hofman, P., and Cundy, T., 2002, The osteodystrophy of mucolipidosis type III and the effects of intravenous pamidronate treatment, J. Inherit. Metab. Dis. 25:681.
26. Rohrer, J., and Kornfeld, R., 2001, Lysosomal hydrolase mannose 6-phosphate uncovering enzyme resides in the trans-Golgi network, Mol. Biol. Cell. 12:1623.
27. Sandoval, I. V., Chen, J. W., Yuan, L., and August, J. T., 1989, Lysosomal integral membrane glycoproteins are expressed at high levels in the inclusion bodies of I-cell disease fibroblasts, Arch. Biochem. Biophys. 271:157.
28. Shows, T. B., Mueller, O. T., Honey, N. K., Wright, C. E., and Miller, A. L., 1982, Genetic heterogeneity of I-cell disease is demonstrated by complementation of lysosomal enzyme processing mutants, Am. J. Med. Genet. 12:343.
29. Sly, W. S., 2000, The missing link in lysosomal enzyme targeting, J. Clin. Invest. 105:563.
30. Spranger, J. W., and Wiedemann, H. R., 1970, The genetic mucolipidoses: Diagnosis and differential diagnosis, Humangenetik. 9:113.
31. Steet, R. A., Hullin, R., Kudo, M., Martinelli, M., Bosshard, N. U., Schaffner, T., Kornfeld, S., and Steinmann, B., 2005, A splicing mutation in the alpha/beta GlcNAc-1-phospho-transferase gene results in an adult onset form of mucolipidosis III associated with sensory neuropathy and cardiomyopathy, Am. J. Med. Genet. 132:369.
32. Taylor, H. A., Thomas, G. H., Miller, C. S., Kelly, T. E., and Siggers, D., 1973, Mucolipi-dosis 3 (pseudo-Hurler polydystrophy): Cytological and ultrastructural observations of cultured fibroblast cells, Clin. Genet. 4:388.
33. Varki, A. P., Reitman, M. L., and Kornfeld, S., 1981, Identification of a variant of mucolipidosis III (pseudo-Hurler polydystrophy): A catalytically active N-acetylglucos-aminylphosphotransferase that fails to phosphorylate lysosomal enzymes, Proc. Natl. Acad. Sci. U S A. 78:7773.
34. Wright, C. E., Miller, A. L., and Shows, T. B., 1979, Complementation analysis of the mucolipidoses demonstrates genetic heterogeneity, Am. J. Hum. Genet. 31:66A.